We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Drug Discovery

Drug Discovery

Stay up to date on the topics that matter to you

Trending News

A baby laying down.

No Adverse Health Risks From Steroids Used for Pre-Term Birth, Study Finds

A ginger haired woman leaning over the arm of a chair.

Scientists Identify Brain Circuit That Suppresses Appetite During Nausea

Immunotherapy attacking a cancer cell.

Immunotherapy Combination Approved for Non-Muscle Invasive Bladder Cancer

Psilocybin Shows Promise for Treatment-Resistant Depression – But Is It Safe?

Phage Therapies for Multidrug-Resistant Infections Should Consider Host Response

First Use of CRISPR-Cas9 Gene Editing in Kissing Bugs

News

Thermo to Sell Cole-Parmer for $480M

Company has signed a definitive agreement to sell its Cole-Parmer channel business to private equity firm GTCR, LLC for $480 million in cash.

Aesica Zwickau Marks 20th Anniversary

Continued growth and expansion of Company’s encapsulation services business.

Innovative Technology Enables First Crystal Structure of mGlu5 Transmembrane Domain to be Determined

Several novel drug candidates have been identified to help treat specific neuropsychiatric disorders.

AstraZeneca Reveals Designs for Cambridge Headquarters

Company revealed the proposed designs for its new Global R&D Centre and Corporate Headquarters in Cambridge in the UK.

Avraham Announces Successful Interim Results in Phase 2b Study of Ladostigil

The next interim results expected at Q3 2015, following 2 years of treatment.

Genticel’s Phase II Study with ProCervix Passes the Halfway Mark for Patient Recruitment

The trial is proceeding as planned, after first DSMB (Data and Safety Monitoring Board) review.

BioLineRx Announces Results from Phase 1/2 Study for Celiac Treatment

Company to investigate lower doses of BL-7010 prior to commencing efficacy study expected in early 2015.

Merck Serono Appoints Luciano Rossetti

Appointment of Rossetti as Executive Vice President and Global Head of Research & Development.

Santhera Repositions Omigapil in Congenital Muscular Dystrophy

Company initiates clinical development program with public-private partners.

immatics Receives €22 Million Final Tranche of Series D Fundraising

Funds will be used to complete phase 3 study with IMA901 and to invest in the expansion of immatics’ Human Immunopeptidome Program to identify the most relevant targets for cancer immunotherapies.

Advertisement

Advertisement

Decoratvive background images

Never miss a story

with the Breaking Science News daily newsletter